FDA cleared the Cyperus from Contrario Medical, Inc. on Oct 26, 2026 under K262276, a traditional 510(k). The device falls under product code MQK, Labware, Assisted Reproduction, regulated at 21 CFR 884.6160 as a Class 2 device. The review panel was Obstetrics/Gynecology.

FDA logged the submission as received on Jul 6, 2026. The decision came 112 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Contrario Medical, Inc. in the last 12 months of the tracker.